Heart failure medication study in Germany
Part of Heart & circulation clinical trials.
This study looks at how well heart failure medicines work in people with a specific type of heart failure called HFrEF. It aims to help doctors understand the best way to use these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in the hospital for at least 24 hours.
- You have been diagnosed with heart failure with reduced pumping strength (ejection fraction 40% or less).
- You are currently taking 2 or fewer of the recommended heart failure medicine types (ACE inhibitors, ARNI, ARBs, beta-blockers, MRAs, or SGLT2 inhibitors).
- You cannot have had a heart transplant.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This trial tests whether it is safe and effective to increase heart failure medications (like ACE inhibitors, ARBs, ARNIs, MRAs, or SGLT-2 inhibitors) without frequent kidney monitoring. It is for people with heart failure and reduced ejection fraction who are not yet on full doses of these medicines.
This study tests an experimental medicine called NNC0537-1482 for people with heart failure. It aims to see if the medicine helps improve symptoms and heart function.
This trial tests if a personalized medication plan can improve health in women hospitalized with heart failure. It aims to find the best treatment combinations for better recovery.
This study looks at how medications are managed in people with heart failure, especially those who have been in the hospital recently for worsening symptoms. It aims to improve treatment strategies.
This study is looking at people with any type of heart failure, whether it's stable and managed at home or newly diagnosed in the hospital. The goal is to learn more about how to improve care, no matter what your ejection fraction level is.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.